Modulari-T Biosciences Analysis: $500K Raised
What is Modulari-T Biosciences?
Modulari-T Biosciences develops modular receptors for safer, cost-effective cell therapies targeting cancer and autoimmune diseases.
Product Features & Capabilities
- MARC technology, modular receptors, persistent immune response, complex and logic gated signaling, compatibility across immune cells, compatibility with iPSC/stem cells, scalable and cost-effective.
How much Modulari-T Biosciences raised
1: - $500,000
April 3, 2023Lead Investor: Y Combinator, Pioneer Fund, Metaplanet
Who are the founders of Modulari-T Biosciences
DW
David White
CEO
SM
Market Focus
Modulari-T Biosciences primarily focuses on the biotechnology industry, specifically in the development of cell therapies for cancer and autoimmune diseases.
Business Model
Focus on partnerships and funding rounds for revenue generation and growth strategy.
Investors
- Y Combinator
- Metaplanet
- Pioneer Fund
- Creative Destruction Lab
- MassBio
Competitors Overview
Modulari-T Biosciences operates in the biotechnology sector, focusing on developing modular receptors for next-generation cell therapies aimed at treating cancer and autoimmune diseases. Its main competitors include:
- Argobio: A French company founded in 2021, Argobio focuses on creating mult
See something that needs updating? Suggest edits to this profile.